Financial Ratios Advanced Medical Solutions Group plc
Stocks
AMS
GB0004536594
Medical Equipment, Supplies & Distribution
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 280.75 GBX | -0.09% |
|
+0.69% | +28.87% |
| 07-20 | Advanced Medical Solutions expects first-half revenue growth | AN |
| 07-20 | Advanced Medical Solutions Group plc Provides Earnings Guidance for the Half Year 2026 | CI |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 5.89 | 5.86 | 4.14 | 2.07 | 3.62 | |||||
Return on Total Capital | 6.6 | 6.64 | 4.72 | 2.41 | 4.23 | |||||
Return On Equity % | 8.43 | 9.08 | 6.61 | 2.94 | 4.02 | |||||
Return on Common Equity | 8.43 | 9.08 | 6.61 | 2.93 | 3.98 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 56.23 | 59.05 | 55.57 | 52.17 | 53.35 | |||||
SG&A Margin | 35.41 | 39.41 | 41.35 | 46.36 | 43.74 | |||||
EBITDA Margin % | 26.4 | 24.89 | 21.07 | 12.79 | 16.18 | |||||
EBITA Margin % | 24.1 | 22.77 | 18.83 | 10.72 | 14.4 | |||||
EBIT Margin % | 21.18 | 20.02 | 14.96 | 6.32 | 9.9 | |||||
Income From Continuing Operations Margin % | 16.1 | 16.41 | 12.59 | 4.02 | 4.41 | |||||
Net Income Margin % | 16.1 | 16.41 | 12.59 | 4 | 4.35 | |||||
Net Avail. For Common Margin % | 16.1 | 16.41 | 12.59 | 4 | 4.35 | |||||
Normalized Net Income Margin | 12.65 | 13.02 | 10.48 | 3.43 | 4.79 | |||||
Levered Free Cash Flow Margin | 20.31 | 11.74 | 1.35 | -9.15 | 4.92 | |||||
Unlevered Free Cash Flow Margin | 20.69 | 12.06 | 1.54 | -7.9 | 6.29 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.45 | 0.47 | 0.44 | 0.52 | 0.58 | |||||
Fixed Assets Turnover | 3.78 | 4.4 | 4.31 | 4.7 | 4.84 | |||||
Receivables Turnover (Average Receivables) | 6.17 | 7.06 | 6.54 | 5.31 | 5.43 | |||||
Inventory Turnover (Average Inventory) | 2.36 | 2.16 | 1.75 | 1.86 | 1.7 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 6.76 | 5.82 | 5.67 | 2.85 | 2.79 | |||||
Quick Ratio | 5.52 | 4.53 | 3.84 | 1.55 | 1.29 | |||||
Operating Cash Flow to Current Liabilities | 1.82 | 1.19 | 0.57 | 0.44 | 0.65 | |||||
Days Sales Outstanding (Average Receivables) | 59.12 | 51.7 | 55.84 | 68.88 | 67.25 | |||||
Days Outstanding Inventory (Average Inventory) | 154.83 | 169.23 | 208.17 | 196.8 | 214.13 | |||||
Average Days Payable Outstanding | 46.49 | 34.63 | 35.94 | 35.3 | 40.71 | |||||
Cash Conversion Cycle (Average Days) | 167.46 | 186.3 | 228.07 | 230.38 | 240.67 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 4.64 | 4.12 | 3.74 | 35.84 | 31.34 | |||||
Total Debt / Total Capital | 4.43 | 3.96 | 3.61 | 26.38 | 23.86 | |||||
LT Debt/Equity | 4.09 | 3.67 | 3.26 | 32.32 | 25.69 | |||||
Long-Term Debt / Total Capital | 3.91 | 3.53 | 3.15 | 23.79 | 19.56 | |||||
Total Liabilities / Total Assets | 14.76 | 15.82 | 15.55 | 37.83 | 34.11 | |||||
EBIT / Interest Expense | 34.22 | 39.01 | 49.17 | 3.15 | 4.49 | |||||
EBITDA / Interest Expense | 44.75 | 50.71 | 73.29 | 7.16 | 8.12 | |||||
(EBITDA - Capex) / Interest Expense | 42.12 | 44.85 | 64.06 | 6.02 | 6.67 | |||||
Total Debt / EBITDA | 0.33 | 0.3 | 0.32 | 3.4 | 1.99 | |||||
Net Debt / EBITDA | -2.1 | -2.24 | -1.81 | 2.73 | 1.55 | |||||
Total Debt / (EBITDA - Capex) | 0.35 | 0.34 | 0.37 | 4.04 | 2.42 | |||||
Net Debt / (EBITDA - Capex) | -2.23 | -2.53 | -2.07 | 3.25 | 1.89 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 25.12 | 14.48 | 1.51 | 40.66 | 28.96 | |||||
Gross Profit, 1 Yr. Growth % | 32.65 | 20.22 | -4.46 | 32.05 | 31.87 | |||||
EBITDA, 1 Yr. Growth % | 78.79 | 7.93 | -14.04 | -14.65 | 63.19 | |||||
EBITA, 1 Yr. Growth % | 89.24 | 8.13 | -16.02 | -19.97 | 73.34 | |||||
EBIT, 1 Yr. Growth % | 98.88 | 8.23 | -24.14 | -40.58 | 102 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 103.65 | 16.73 | -22.14 | -55.05 | 41.35 | |||||
Net Income, 1 Yr. Growth % | 103.65 | 16.73 | -22.14 | -55.35 | 40.32 | |||||
Normalized Net Income, 1 Yr. Growth % | 101.26 | 17.86 | -18.34 | -53.93 | 80.15 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 103.3 | 16.11 | -22.04 | -55.17 | 39.08 | |||||
Accounts Receivable, 1 Yr. Growth % | -0.84 | 1.11 | 18.06 | 119.56 | -16.23 | |||||
Inventory, 1 Yr. Growth % | -8.2 | 44.62 | 29.15 | 53.3 | 26.76 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -8.72 | 5.74 | 2.02 | 54.96 | 6.28 | |||||
Total Assets, 1 Yr. Growth % | 4.59 | 12.66 | 2.87 | 34.35 | 1.61 | |||||
Tangible Book Value, 1 Yr. Growth % | 17.78 | 14.71 | -3.27 | -58.68 | 55.34 | |||||
Common Equity, 1 Yr. Growth % | 5.18 | 11.26 | 3.2 | -1.4 | 7.48 | |||||
Cash From Operations, 1 Yr. Growth % | 44.23 | -13.37 | -54.07 | 57.87 | 67.21 | |||||
Capital Expenditures, 1 Yr. Growth % | -24.64 | 111.48 | -5.22 | 14.48 | 81.37 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 95.68 | -33.79 | -88.34 | -1.05K | -169.31 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 92.02 | -33.26 | -87.05 | -821.7 | -202.81 | |||||
Dividend Per Share, 1 Yr. Growth % | 14.71 | 10.26 | 9.77 | 10.17 | 10 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 3 | 19.68 | 7.8 | 19.49 | 34.68 | |||||
Gross Profit, 2 Yr. CAGR % | 0.48 | 26.28 | 7.17 | 12.32 | 31.96 | |||||
EBITDA, 2 Yr. CAGR % | -0.69 | 38.91 | -3.68 | -14.35 | 18.02 | |||||
EBITA, 2 Yr. CAGR % | -1.5 | 43.04 | -4.71 | -18.02 | 17.78 | |||||
EBIT, 2 Yr. CAGR % | -4.65 | 46.71 | -9.39 | -32.86 | 9.55 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -3.88 | 54.18 | -4.66 | -40.84 | -20.29 | |||||
Net Income, 2 Yr. CAGR % | -3.88 | 54.18 | -4.66 | -41.04 | -20.85 | |||||
Normalized Net Income, 2 Yr. CAGR % | -6.8 | 54.01 | -1.9 | -38.67 | -8.9 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -4.16 | 53.64 | -4.86 | -40.88 | -21.04 | |||||
Accounts Receivable, 2 Yr. CAGR % | -17.33 | 0.13 | 9.26 | 61 | 35.62 | |||||
Inventory, 2 Yr. CAGR % | 4.56 | 15.22 | 36.66 | 40.71 | 39.4 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | -0.48 | -1.76 | 3.86 | 25.74 | 28.33 | |||||
Total Assets, 2 Yr. CAGR % | 4.84 | 8.55 | 7.66 | 17.56 | 16.84 | |||||
Tangible Book Value, 2 Yr. CAGR % | 3.05 | 16.23 | 5.34 | -36.78 | -19.88 | |||||
Common Equity, 2 Yr. CAGR % | 5.46 | 8.17 | 7.16 | 0.87 | 2.94 | |||||
Cash From Operations, 2 Yr. CAGR % | 19.57 | 11.78 | -36.92 | -14.85 | 62.47 | |||||
Capital Expenditures, 2 Yr. CAGR % | -18.67 | 26.24 | 41.58 | 4.17 | 44.09 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 46.34 | 13.82 | -72.22 | 5.47 | 157.14 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 44.53 | 13.21 | -70.6 | -3.33 | 172.39 | |||||
Dividend Per Share, 2 Yr. CAGR % | 12.16 | 12.46 | 10.01 | 9.97 | 10.08 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 1.91 | 6.69 | 13.29 | 17.8 | 22.57 | |||||
Gross Profit, 3 Yr. CAGR % | -1.24 | 6.67 | 15.06 | 14.89 | 18.49 | |||||
EBITDA, 3 Yr. CAGR % | -2.7 | 2.11 | 18.37 | -7.48 | 6.18 | |||||
EBITA, 3 Yr. CAGR % | -3.31 | 1.61 | 19.77 | -10.09 | 5.22 | |||||
EBIT, 3 Yr. CAGR % | -7.31 | -0.54 | 17.76 | -21.28 | -3.08 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -8.05 | 2.55 | 22.78 | -25.8 | -20.91 | |||||
Net Income, 3 Yr. CAGR % | -8.05 | 2.55 | 22.78 | -25.96 | -21.28 | |||||
Normalized Net Income, 3 Yr. CAGR % | -8.47 | 0.78 | 24.65 | -23.75 | -12.17 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -8.37 | 2.17 | 22.54 | -25.97 | -21.38 | |||||
Accounts Receivable, 3 Yr. CAGR % | -10.78 | -11.59 | 5.78 | 37.88 | 29.5 | |||||
Inventory, 3 Yr. CAGR % | 9.25 | 16.49 | 19.69 | 42 | 35.9 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | -0.49 | 1.55 | -0.52 | 18.68 | 18.88 | |||||
Total Assets, 3 Yr. CAGR % | 6.73 | 7.39 | 6.62 | 15.9 | 11.99 | |||||
Tangible Book Value, 3 Yr. CAGR % | -0.62 | 6.8 | 9.33 | -22.89 | -14.69 | |||||
Common Equity, 3 Yr. CAGR % | 7.18 | 7.36 | 6.49 | 4.22 | 3.03 | |||||
Cash From Operations, 3 Yr. CAGR % | 12.7 | 7.39 | -16.9 | -14.36 | 6.63 | |||||
Capital Expenditures, 3 Yr. CAGR % | -16.73 | 11.84 | 14.74 | 31.9 | 25.31 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 17.18 | 12.34 | -46.74 | -9.7 | -8.31 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 16.9 | 11.72 | -45.05 | -14.56 | -1.33 | |||||
Dividend Per Share, 3 Yr. CAGR % | 13.89 | 11.52 | 11.55 | 10.06 | 9.98 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 5.46 | 5.11 | 4.23 | 11.64 | 21.41 | |||||
Gross Profit, 5 Yr. CAGR % | 4.91 | 4.68 | 2.04 | 8.9 | 21.55 | |||||
EBITDA, 5 Yr. CAGR % | 5.82 | 2.44 | -3.09 | -4.82 | 18.23 | |||||
EBITA, 5 Yr. CAGR % | 5.84 | 2.21 | -3.87 | -6.75 | 18.97 | |||||
EBIT, 5 Yr. CAGR % | 3.39 | -0.28 | -8.15 | -15.01 | 14.4 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 2.18 | 0.27 | -6.71 | -17.7 | 3.3 | |||||
Net Income, 5 Yr. CAGR % | 2.18 | 0.27 | -6.71 | -17.81 | 3.01 | |||||
Normalized Net Income, 5 Yr. CAGR % | 2.47 | 0.5 | -5.9 | -17.38 | 9.96 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 1.65 | -0.19 | -6.98 | -17.91 | 2.79 | |||||
Accounts Receivable, 5 Yr. CAGR % | 10.87 | -1.44 | -3.25 | 12.37 | 16.84 | |||||
Inventory, 5 Yr. CAGR % | 11.03 | 20.31 | 19.49 | 25.63 | 27.21 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 11.15 | 11.26 | 1.23 | 10.61 | 10.15 | |||||
Total Assets, 5 Yr. CAGR % | 11.47 | 10.75 | 7.1 | 11.35 | 10.6 | |||||
Tangible Book Value, 5 Yr. CAGR % | 9.67 | 6.36 | 1.72 | -13.41 | -3.45 | |||||
Common Equity, 5 Yr. CAGR % | 11.12 | 9.19 | 7.17 | 4.72 | 5.06 | |||||
Cash From Operations, 5 Yr. CAGR % | 9.37 | 9.64 | -10.65 | -2.13 | 8.66 | |||||
Capital Expenditures, 5 Yr. CAGR % | 3.03 | 5.21 | 2.97 | 8.7 | 25.69 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 8.73 | 24.88 | -34.11 | 9.54 | -0.02 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 9.14 | 25.56 | -32.7 | 5.44 | 4.25 | |||||
Dividend Per Share, 5 Yr. CAGR % | 16.21 | 14.34 | 12.32 | 10.9 | 10.96 |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















